SavedAdd your journal

Journals / Marmara Medical Journal / 2026 / Volume: 27 Issue: 2

Recurrence of nasopharyngeal carcinoma in the mastoid region: Therapeutic approach of a rare clinical entity

Nazofarenks kanserinin mastoid bölge rekürrensi: Nadir bir klinik tablonun tedavisi

Ayşegül Üçüncü Kefeli
Beste Melek Atasoy
Zerrin Özgen
Murat Sarı
Fuat Dede
Faysal Dane
Pages
—
Publication Date
2014-05-20
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This paper presents a patient with an isolated mastoid recurrence following definitive treatment and discusses the therapeutic approach which may help in the treatment of such cases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Mastoid region recurrence is a rare entity for nasopharyngeal cancer.
📊
Key Findings & Data:Mastoid region recurrence is a rare entity for nasopharyngeal cancer.
💡
Conclusion & Impact:This paper presents a patient with an isolated mastoid recurrence following definitive treatment and discusses the therapeutic approach which may help in the treatment of such cases.
🔬Design:Case Report
📍Scope:Comprehensive Sample
⚙️Variables:Chemotherapy · Mastoid region recurrence · Nasopharyngeal carcinoma

Abstract

Mastoid region recurrence is a rare entity for nasopharyngeal cancer. This paper presents a patient with an isolated mastoid recurrence following definitive treatment and discusses the therapeutic approach which may help in the treatment of such cases.

Özet

Nazofarenks kanserinde mastoid rekürrens takipte nadir izlenen bir durumdur. Bu makale definitif tedavi sonrası izlenen izole mastoid nüksünü sunmakta ve tedavisini tartışmaktadır.

🔖

Cite This Article

Kefeli, A. Ü., Atasoy, B. M., Özgen, Z., Sarı, M., Dede, F., Dane, F. (2014). Recurrence of nasopharyngeal carcinoma in the mastoid region: Therapeutic approach of a rare clinical entity. Marmara Medical Journal, Volume: 27 Issue: 2. https://ajindex.com/articles/1286882

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Lee AW, Lin JC, Ng WT. Current management of nasopharyngeal cancer. Semin Radiat Oncol 2012;22:233-44. doi:10.1016/j. semradonc.2012.03.008
  2. Atasoy BM, Ozyar E, Akman F, Esassolak M, Abacioğlu U. T4N0M0 nasopharyngeal carcinoma patients: do they have a distinct tumor biology? Kulak Burun Bogaz Ihtis Derg 2010;20:89-96.
  3. Atasoy BM, Dane F, Yumuk PF, et al. Toxicity and feasibility analysis for cisplatin-based concomitant chemoradiotherapy in locally advanced nasopharyngeal carcinoma. J BUON 2008;13:43-50.
  4. Zhang X, Luo J, Gao L, Xu G. Mastoid recurrence after radiotherapy for nasopharyngeal carcinoma: two case studies. Head Neck 2011;33:1535-8. doi: 10.1002/hed.21391
  5. Yang MS, Chen CC, Cheng YY, et al. Nasopharyngeal carcinoma spreading along the eustachian tube: the imaging appearance. J Chin Med Assoc 2004;67:200-3.
  6. Dubrulle F, Souillard R, Hermans R. Extension patterns of nasopharyngeal carcinoma. Eur Radiol 2007;17:2622-30. doi:10.1007/s00330-007-0616-z
  7. Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging handbook from the AJCC cancer staging manual. 6th ed. New York, Springer: 2002.